Baird Financial Group
FLGT icon

Baird Financial Group’s Fulgent Genetics FLGT Stock Holding History

Baird Financial Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,210
Closed -$200K – 1798
2022
Q1 		$200K Sell
3,210
-288
-8% -$19K ﹤0.01% 1753
2021
Q4 		$352K Buy
3,498
+670
+24% +$58.9K ﹤0.01% 1604
2021
Q3 		$254K Buy
2,828
+505
+22% +$45.9K ﹤0.01% 1724
2021
Q2 		$214K Buy
+2,323
New +$185K ﹤0.01% 1677

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baird Financial Group's FLGT Position: Q2 2022 in Review

Baird Financial Group sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 3,210 shares — an estimated $200K sold.

Baird Financial Group first reported a position in FLGT in Q2 2021 and held it in 4 quarters. The position peaked at $352K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Baird Financial Group reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Baird Financial Group sold 3,210 Fulgent Genetics shares in Q2 2022, an estimated $200K.
  • Baird Financial Group first reported a position in Fulgent Genetics in Q2 2021 and held it in 4 quarters.
  • Baird Financial Group's Fulgent Genetics position peaked at $352K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Baird Financial Group's 13F filing for Q2 2022, filed 8 Aug 2022.